Lakeshore Hyperbaric Center
- Hyperbaric Oxygen Therapy (HBOT)
- Multiple Sclerosis (MS) Treatment
- Lyme Disease Treatment
- Migraine Treatment
- Stem Cell Therapy
Chicago, IL
Migraine care in Chicago blends headache medicine anchored around Northwestern Medicine, Rush, UChicago Medicine, and Cook County Health with integrative clinics offering IV magnesium, nerve blocks, and peptide protocols. Demand reflects a dense, racially and economically diverse metropolitan population.
Evidence-based care uses triptans, gepants, lasmiditan, and anti-CGRP monoclonals for acute and preventive treatment, plus onabotulinumtoxinA for chronic migraine and FDA-cleared neuromodulation devices. Regenerative and integrative adjuncts in Chicago, Illinois include IV magnesium, occipital and sphenopalatine ganglion blocks, ketamine infusions for refractory cases, and HBOT (investigational for cluster headache). Illinois Department of Financial and Professional Regulation oversight of physicians and medspas shapes prescribing and compounding authority.
With migraine clinics on Regenerated.com in Chicago, patients can compare whether a clinic offers a proper headache workup, follows ICHD-3 criteria, and clearly distinguishes FDA-approved from off-label options.
Regulatory context
Repetitive transcranial magnetic stimulation (rTMS) is regulated as a Class II prescription device. The first 510(k) clearance went to NeuroStar in 2008 for treatment-resistant major depressive disorder. Subsequent clearances expanded the on-label scope to obsessive-compulsive disorder (BrainsWay deep TMS, 2018), smoking cessation (BrainsWay, 2020), anxious depression as an adjunct indication (2021), and migraine via single-pulse TMS devices such as eNeura SpringTMS and SAVI Dual. Biofeedback instruments are cleared under 21 CFR 882.1425 as Class II devices for relaxation training and stress reduction. EEG-based neurofeedback systems hold 510(k) clearances in the same category. Cranial electrotherapy stimulation, tDCS wellness devices, and many vagus nerve stimulation accessories sold direct to consumers are not cleared as medical devices, and clinical claims beyond cleared indications are off-label.
The Illinois Department of Financial and Professional Regulation investigates TMS clinics for supervision deficiencies, corporate practice violations, and off-label marketing. Illinois has a strong corporate practice of medicine doctrine that shapes TMS and neurofeedback clinic ownership structures. The Illinois attorney general has pursued Consumer Fraud Act actions against neurofeedback providers making cure claims for autism, ADHD, or learning disabilities. Commercial insurers and Illinois Medicaid managed care contractors require documented treatment-resistant depression before covering TMS for major depression.